Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Doximity (DOCS) Cash & Equivalents (2021 - 2025)

Doximity has reported Cash & Equivalents over the past 5 years, most recently at $64.8 million for Q4 2025.

  • Quarterly Cash & Equivalents fell 60.77% to $64.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $64.8 million through Dec 2025, down 60.77% year-over-year, with the annual reading at $209.6 million for FY2025, 116.58% up from the prior year.
  • Cash & Equivalents was $64.8 million for Q4 2025 at Doximity, down from $169.2 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $594.3 million in Q2 2021 and troughed at $64.8 million in Q4 2025.
  • The 5-year median for Cash & Equivalents is $117.9 million (2022), against an average of $154.7 million.
  • Year-over-year, Cash & Equivalents crashed 81.48% in 2022 and then skyrocketed 178.61% in 2023.
  • A 5-year view of Cash & Equivalents shows it stood at $85.1 million in 2021, then surged by 60.39% to $136.5 million in 2022, then fell by 9.79% to $123.1 million in 2023, then skyrocketed by 34.27% to $165.3 million in 2024, then plummeted by 60.77% to $64.8 million in 2025.
  • Per Business Quant, the three most recent readings for DOCS's Cash & Equivalents are $64.8 million (Q4 2025), $169.2 million (Q3 2025), and $137.3 million (Q2 2025).